Surgical robotics is changing the landscape in healthcare. Stereotaxis is hoping to carve out its niche in the massive space, which is home to Intuitive Surgical, Johnson & Johnson, and Medtronic.
David Fischel, the St. Louis, MO-based company’s chairman and CEO, is featured in this episode of Let’s Talk Medtech to discuss Stereotaxis’ journey from surviving to thriving. The firm recently secured $50 million in funding and has had strong collaborations with NVIDIA.
Fischel talks about the company’s game plan and his thoughts on the future of surgical robotics.
Podden och tillhörande omslagsbild på den här sidan tillhör
Informa Markets. Innehållet i podden är skapat av Informa Markets och inte av,
eller tillsammans med, Poddtoppen.
